|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑
$ \7 P7 ?$ N, Q) A1 N$ _ y0 z, r3 N: d2 S# W h
今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况6 _0 }+ O( f* h+ q4 t9 \" u/ j/ i
+ l. \+ s% x* Z# X1 \6 O
LB2. TransRadial versus transfemoral Arterial access for CErebral angiography
0 N" x+ \! c7 g5 CWei Ni, Huashan Hospital, Fudan University, Shanghai, China5 G) T, M% w, o; Q; O# W# H( s
' } I& M/ a: C7 C# _
LB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
3 U6 W- |# ^# U/ {8 |. q- ?% O- E1 M0 ?6 ]Xuening Zhang, West China Hospital, Sichuan University, Chendu, China! J% n. s$ N' ]. k, ]2 e
+ Q. I) G. w: w3 Z1 u0 ~& LLB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
# H( n$ O8 z+ Z1 r9 Q( RMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China
6 |6 [' e! \( j( v& b8 I+ M! D( K3 [1 b9 \3 |5 Y
LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail8 D" u4 }% M6 z
Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China
' R3 R$ |; d: K2 }# b! \) W y1 |& m
LB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours
! O1 U+ d! m( O. T+ l0 b5 fMin Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China+ S f& J, {4 h
( [2 w- D, Q4 @! ^LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial; o+ o5 M2 V$ @
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
7 k0 `% I; E& M3 D- [2 k: X7 R& \8 L! y9 h( D" f" c @( }
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial8 T% s6 D% v: a# ]6 E& [# h
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China# w3 n( M y9 j$ X
' E/ L7 b* A- z3 q: W" H
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
, U0 w% L7 [$ \+ hYarong Ding, Beijing Tiantan Hospital, Beijing, China0 g' d; Q+ O! E; _; b
$ x; S( s, \* A0 O- f. i
祝贺以上单位！
+ D! a' d0 o* g6 u# d( J0 H |
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
